Pharmacokinetics of sulfadimethoxine and sulfamethoxazole in combination with trimethoprim after oral single- and multiple-dose administration to healthy pigs. 2001

M J Mengelers, and E R van Gogh, and M B Huveneers, and P E Hougee, and H A Kuiper, and A Pijpers, and J H Verheijden, and A S van Miert
State Institute for Quality Control of Agricultural Products, Department of Toxicology, Wageningen, The Netherlands.

The pharmacokinetics were studied of sulfadimethoxine (SDM) or sulfamethoxazole (SMX) in combination with trimethoprim (TMP) administered as a single oral dose (25 mg + 5 mg per kg body weight) to two groups of 6 healthy pigs. The elimination half-lives of SMX and TMP were quite similar (2-3 h); SDM had a relatively long half-life of 13 h. Both sulfonamides (S) were exclusively metabolized to N4-acetyl derivatives but to different extents. The main metabolic pathway for TMP was O-demethylation and subsequent conjugation. In addition, the plasma concentrations of these drugs and their main metabolites after medication with different in-feed concentrations were determined. The drug (S:TMP) concentrations in the feed were 250:50, 500:100, and 1000:200 mg per kg. Steady-state concentrations were achieved within 48 h of feed medication, twice daily (SDM+TMP) or three times a day (SMX+TMP). Protein binding of SDM and its metabolite was high (>93%), whereas SMX, TMP and their metabolites showed moderate binding (48-75%). Feed medication with 500 ppm sulfonamide combined with 100 ppm TMP provided minimum steady-state plasma concentrations (C(ss,min)) higher than the concentration required for inhibition of the growth of 90% of Actinobacillus pleuropneumoniae strains (n = 20).

UI MeSH Term Description Entries
D008297 Male Males
D004338 Drug Combinations Single preparations containing two or more active agents, for the purpose of their concurrent administration as a fixed dose mixture. Drug Combination,Combination, Drug,Combinations, Drug
D006207 Half-Life The time it takes for a substance (drug, radioactive nuclide, or other) to lose half of its pharmacologic, physiologic, or radiologic activity. Halflife,Half Life,Half-Lifes,Halflifes
D000284 Administration, Oral The giving of drugs, chemicals, or other substances by mouth. Drug Administration, Oral,Administration, Oral Drug,Oral Administration,Oral Drug Administration,Administrations, Oral,Administrations, Oral Drug,Drug Administrations, Oral,Oral Administrations,Oral Drug Administrations
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D000821 Animal Feed Foodstuff used especially for domestic and laboratory animals, or livestock. Fodder,Animal Feeds,Feed, Animal,Feeds, Animal,Fodders
D000890 Anti-Infective Agents Substances that prevent infectious agents or organisms from spreading or kill infectious agents in order to prevent the spread of infection. Anti-Infective Agent,Anti-Microbial Agent,Antimicrobial Agent,Microbicide,Microbicides,Anti-Microbial Agents,Antiinfective Agents,Antimicrobial Agents,Agent, Anti-Infective,Agent, Anti-Microbial,Agent, Antimicrobial,Agents, Anti-Infective,Agents, Anti-Microbial,Agents, Antiinfective,Agents, Antimicrobial,Anti Infective Agent,Anti Infective Agents,Anti Microbial Agent,Anti Microbial Agents
D013412 Sulfadimethoxine A sulfanilamide that is used as an anti-infective agent. Deposul,Sulphadimethoxine
D013552 Swine Any of various animals that constitute the family Suidae and comprise stout-bodied, short-legged omnivorous mammals with thick skin, usually covered with coarse bristles, a rather long mobile snout, and small tail. Included are the genera Babyrousa, Phacochoerus (wart hogs), and Sus, the latter containing the domestic pig (see SUS SCROFA). Phacochoerus,Pigs,Suidae,Warthogs,Wart Hogs,Hog, Wart,Hogs, Wart,Wart Hog
D015662 Trimethoprim, Sulfamethoxazole Drug Combination A drug combination with broad-spectrum antibacterial activity against both gram-positive and gram-negative organisms. It is effective in the treatment of many infections, including PNEUMOCYSTIS PNEUMONIA in AIDS. Trimethoprim-Sulfamethoxazole Combination,Abactrim,Bactifor,Bactrim,Biseptol,Biseptol-480,Centran,Centrin,Co-Trimoxazole,Cotrimoxazole,Drylin,Eslectin,Eusaprim,Insozalin,Kepinol,Kepinol Forte,Lescot,Metomide,Oriprim,Septra,Septrin,Sulfamethoxazole-Trimethoprim Combination,Sulprim,Sumetrolim,TMP SMX,TMP-SMX,Trimedin,Trimethoprim-Sulfamethoxazole,Trimethoprimsulfa,Trimezole,Trimosulfa,Biseptol 480,Biseptol480,Co Trimoxazole,Sulfamethoxazole Trimethoprim Combination,Trimethoprim Sulfamethoxazole,Trimethoprim Sulfamethoxazole Combination

Related Publications

M J Mengelers, and E R van Gogh, and M B Huveneers, and P E Hougee, and H A Kuiper, and A Pijpers, and J H Verheijden, and A S van Miert
January 1973, Chemotherapy,
M J Mengelers, and E R van Gogh, and M B Huveneers, and P E Hougee, and H A Kuiper, and A Pijpers, and J H Verheijden, and A S van Miert
June 2017, Environmental toxicology and pharmacology,
M J Mengelers, and E R van Gogh, and M B Huveneers, and P E Hougee, and H A Kuiper, and A Pijpers, and J H Verheijden, and A S van Miert
January 2011, Journal of biomedical research,
M J Mengelers, and E R van Gogh, and M B Huveneers, and P E Hougee, and H A Kuiper, and A Pijpers, and J H Verheijden, and A S van Miert
September 1993, Journal of pharmaceutical sciences,
M J Mengelers, and E R van Gogh, and M B Huveneers, and P E Hougee, and H A Kuiper, and A Pijpers, and J H Verheijden, and A S van Miert
September 1994, Journal of pharmaceutical sciences,
M J Mengelers, and E R van Gogh, and M B Huveneers, and P E Hougee, and H A Kuiper, and A Pijpers, and J H Verheijden, and A S van Miert
June 2023, Journal of avian medicine and surgery,
M J Mengelers, and E R van Gogh, and M B Huveneers, and P E Hougee, and H A Kuiper, and A Pijpers, and J H Verheijden, and A S van Miert
September 2006, Journal of clinical pharmacology,
M J Mengelers, and E R van Gogh, and M B Huveneers, and P E Hougee, and H A Kuiper, and A Pijpers, and J H Verheijden, and A S van Miert
October 1988, British journal of clinical pharmacology,
M J Mengelers, and E R van Gogh, and M B Huveneers, and P E Hougee, and H A Kuiper, and A Pijpers, and J H Verheijden, and A S van Miert
April 2009, American journal of veterinary research,
M J Mengelers, and E R van Gogh, and M B Huveneers, and P E Hougee, and H A Kuiper, and A Pijpers, and J H Verheijden, and A S van Miert
May 1996, Journal of clinical pharmacology,
Copied contents to your clipboard!